Focal Segmental Glomerulosclerosis (FSGS) Completed Phase 1 / 2 Trials for Cyclophosphamide (DB00531)

Also known as: Focal Glomerulosclerosis / Glomerulosclerosis, Focal / Focal Segmental Glomerulosclerosis / Glomerulosclerosis, Focal Segmental / APOL1-mediated focal segmental glomerulosclerosis / Focal & segmental glomerulosclerosis / Focal glomerular sclerosis (disorder) / Focal segmental glomerulosclerosis (disorder)

IndicationStatusPhase
DBCOND0038485 (Focal Segmental Glomerulosclerosis (FSGS))Completed1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00007475Permeability Factor in Focal Segmental GlomerulosclerosisTreatment